Interleukin‐37 improves T‐cell‐mediated immunity and chimeric antigen receptor T‐cell therapy in aged backgrounds

Aging‐associated declines in innate and adaptive immune responses are well documented and pose a risk for the growing aging population, which is predicted to comprise greater than 40 percent of the world's population by 2050. Efforts have been made to improve immunity in aged populations; howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamilton, Jamie A. G., Lee, Miyoung Y., Hunter, Rae, Ank, Raira S., Story, Jamie Y., Talekar, Ganesh, Sisroe, Talia, Ballak, Dov B., Fedanov, Andrew, Porter, Christopher C., Eisenmesser, Elan Z., Dinarello, Charles A., Raikar, Sunil S., DeGregori, James, Henry, Curtis J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884049/
https://www.ncbi.nlm.nih.gov/pubmed/33480151
http://dx.doi.org/10.1111/acel.13309

Ejemplares similares

Ejemplares similares